Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Investor's Business Daily on MSN4h
Is Larry Ellison Moderna's Saving Grace? Is Moderna Stock Now A Buy?
Moderna expects the Food and Drug Administration to make an approval decision on its next-generation Covid vaccine in late May. The company is also working to expand its RSV vaccine to people younger ...